Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Non-Hodgkin | 10 | 2015 | 261 | 2.390 |
Why?
|
Diet | 16 | 2017 | 443 | 2.030 |
Why?
|
Feeding Behavior | 7 | 2016 | 324 | 1.760 |
Why?
|
Microbiota | 8 | 2023 | 381 | 1.630 |
Why?
|
Rheumatic Heart Disease | 7 | 2024 | 29 | 1.580 |
Why?
|
Colorectal Neoplasms | 6 | 2022 | 938 | 1.370 |
Why?
|
Heart Defects, Congenital | 8 | 2023 | 351 | 1.270 |
Why?
|
Mothers | 3 | 2021 | 141 | 0.990 |
Why?
|
Vegetables | 3 | 2013 | 45 | 0.990 |
Why?
|
Fruit | 3 | 2013 | 75 | 0.970 |
Why?
|
Postmenopause | 4 | 2013 | 98 | 0.970 |
Why?
|
Cardiopulmonary Bypass | 2 | 2023 | 148 | 0.920 |
Why?
|
Child | 35 | 2024 | 6927 | 0.900 |
Why?
|
Nutritional Status | 2 | 2014 | 83 | 0.900 |
Why?
|
Female | 75 | 2024 | 44532 | 0.850 |
Why?
|
Humans | 103 | 2024 | 86643 | 0.820 |
Why?
|
Cohort Studies | 21 | 2024 | 2767 | 0.810 |
Why?
|
Health Behavior | 3 | 2011 | 183 | 0.780 |
Why?
|
Weight Perception | 1 | 2020 | 1 | 0.750 |
Why?
|
Mother-Child Relations | 1 | 2020 | 26 | 0.740 |
Why?
|
Virtual Reality | 4 | 2023 | 21 | 0.730 |
Why?
|
Body Image | 1 | 2020 | 76 | 0.720 |
Why?
|
Risk Factors | 23 | 2023 | 5417 | 0.710 |
Why?
|
Male | 62 | 2024 | 40965 | 0.700 |
Why?
|
Case-Control Studies | 15 | 2021 | 1805 | 0.700 |
Why?
|
Adolescent | 29 | 2024 | 8981 | 0.680 |
Why?
|
Pediatrics | 7 | 2021 | 344 | 0.680 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 212 | 0.670 |
Why?
|
Infant | 16 | 2024 | 3046 | 0.670 |
Why?
|
Retrospective Studies | 29 | 2024 | 8489 | 0.620 |
Why?
|
Surveys and Questionnaires | 9 | 2020 | 2501 | 0.560 |
Why?
|
Urine | 1 | 2016 | 90 | 0.560 |
Why?
|
Aged | 30 | 2023 | 18415 | 0.560 |
Why?
|
Meat Products | 2 | 2012 | 7 | 0.540 |
Why?
|
C-Reactive Protein | 2 | 2014 | 190 | 0.530 |
Why?
|
Food | 2 | 2015 | 86 | 0.530 |
Why?
|
Soy Foods | 2 | 2011 | 3 | 0.530 |
Why?
|
Young Adult | 20 | 2024 | 5976 | 0.520 |
Why?
|
Calcium, Dietary | 1 | 2015 | 63 | 0.520 |
Why?
|
Rheumatic Fever | 3 | 2024 | 12 | 0.510 |
Why?
|
Premature Birth | 1 | 2016 | 113 | 0.510 |
Why?
|
Middle Aged | 31 | 2023 | 25028 | 0.500 |
Why?
|
Adolescent Nutritional Physiological Phenomena | 1 | 2014 | 3 | 0.500 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2014 | 12 | 0.500 |
Why?
|
Adult | 31 | 2023 | 25648 | 0.480 |
Why?
|
Proportional Hazards Models | 11 | 2023 | 859 | 0.470 |
Why?
|
Leptin | 2 | 2014 | 105 | 0.470 |
Why?
|
Curriculum | 6 | 2023 | 539 | 0.460 |
Why?
|
Energy Intake | 5 | 2017 | 98 | 0.460 |
Why?
|
Carotenoids | 2 | 2013 | 14 | 0.460 |
Why?
|
Adiponectin | 1 | 2013 | 24 | 0.450 |
Why?
|
Diet, Western | 1 | 2013 | 37 | 0.450 |
Why?
|
Phytanic Acid | 1 | 2012 | 3 | 0.450 |
Why?
|
Irritable Bowel Syndrome | 2 | 2023 | 45 | 0.440 |
Why?
|
Hawaii | 10 | 2016 | 26 | 0.440 |
Why?
|
Smoking | 3 | 2013 | 609 | 0.440 |
Why?
|
Gastrointestinal Microbiome | 3 | 2023 | 455 | 0.430 |
Why?
|
Heterocyclic Compounds | 1 | 2012 | 17 | 0.430 |
Why?
|
Amines | 1 | 2012 | 27 | 0.430 |
Why?
|
Food Supply | 1 | 2012 | 28 | 0.430 |
Why?
|
Somatomedins | 1 | 2012 | 28 | 0.420 |
Why?
|
Heart | 4 | 2023 | 539 | 0.420 |
Why?
|
Phytoestrogens | 1 | 2011 | 2 | 0.420 |
Why?
|
Isoflavones | 1 | 2011 | 13 | 0.420 |
Why?
|
Growth Inhibitors | 1 | 2011 | 41 | 0.420 |
Why?
|
Prospective Studies | 15 | 2024 | 4213 | 0.420 |
Why?
|
Fabaceae | 1 | 2011 | 25 | 0.420 |
Why?
|
Heart Ventricles | 4 | 2021 | 760 | 0.410 |
Why?
|
Heart Transplantation | 3 | 2022 | 705 | 0.410 |
Why?
|
Lung Transplantation | 2 | 2024 | 175 | 0.410 |
Why?
|
Infant, Newborn | 11 | 2024 | 2379 | 0.400 |
Why?
|
Cardiac Volume | 2 | 2022 | 53 | 0.400 |
Why?
|
Crohn Disease | 3 | 2023 | 730 | 0.390 |
Why?
|
Food Labeling | 1 | 2010 | 8 | 0.380 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 508 | 0.380 |
Why?
|
Aortic Diseases | 2 | 2023 | 100 | 0.380 |
Why?
|
Fontan Procedure | 2 | 2020 | 53 | 0.370 |
Why?
|
Social Determinants of Health | 3 | 2021 | 78 | 0.370 |
Why?
|
Health Status Disparities | 2 | 2014 | 170 | 0.360 |
Why?
|
Acute Kidney Injury | 2 | 2024 | 295 | 0.360 |
Why?
|
Communication | 3 | 2018 | 441 | 0.360 |
Why?
|
Child, Preschool | 10 | 2023 | 3612 | 0.350 |
Why?
|
Papillomavirus Vaccines | 2 | 2022 | 58 | 0.350 |
Why?
|
Body Mass Index | 8 | 2021 | 770 | 0.340 |
Why?
|
Endometrial Neoplasms | 1 | 2011 | 193 | 0.340 |
Why?
|
Body Weight | 3 | 2023 | 459 | 0.340 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2023 | 318 | 0.330 |
Why?
|
Papillomavirus Infections | 3 | 2022 | 239 | 0.320 |
Why?
|
Nutrition Surveys | 3 | 2014 | 114 | 0.320 |
Why?
|
California | 6 | 2016 | 138 | 0.320 |
Why?
|
RNA, Ribosomal, 16S | 5 | 2023 | 241 | 0.310 |
Why?
|
Blood Glucose | 1 | 2012 | 873 | 0.310 |
Why?
|
Infant Care | 2 | 2017 | 6 | 0.310 |
Why?
|
Risk Assessment | 6 | 2021 | 2261 | 0.300 |
Why?
|
Vaccination Refusal | 2 | 2017 | 10 | 0.300 |
Why?
|
Child Development | 2 | 2021 | 163 | 0.300 |
Why?
|
Diet Records | 3 | 2017 | 19 | 0.300 |
Why?
|
Metagenome | 3 | 2022 | 102 | 0.300 |
Why?
|
Obesity | 4 | 2015 | 963 | 0.290 |
Why?
|
Uganda | 5 | 2024 | 34 | 0.290 |
Why?
|
Insulin | 1 | 2012 | 1160 | 0.290 |
Why?
|
United States | 11 | 2021 | 6672 | 0.280 |
Why?
|
Nutrition Assessment | 4 | 2016 | 21 | 0.280 |
Why?
|
Milk, Human | 2 | 2016 | 43 | 0.280 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2023 | 549 | 0.280 |
Why?
|
Education, Medical, Graduate | 3 | 2019 | 369 | 0.280 |
Why?
|
Imaging, Three-Dimensional | 2 | 2020 | 579 | 0.280 |
Why?
|
Cardiac Surgical Procedures | 2 | 2021 | 462 | 0.270 |
Why?
|
Colitis, Ulcerative | 2 | 2023 | 711 | 0.270 |
Why?
|
Follow-Up Studies | 8 | 2021 | 3640 | 0.270 |
Why?
|
Reproducibility of Results | 6 | 2023 | 2705 | 0.270 |
Why?
|
Cross-Sectional Studies | 5 | 2016 | 1621 | 0.270 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 484 | 0.270 |
Why?
|
Pregnancy | 7 | 2023 | 2894 | 0.260 |
Why?
|
Hospitalization | 2 | 2021 | 849 | 0.250 |
Why?
|
Breast Neoplasms | 3 | 2013 | 2903 | 0.250 |
Why?
|
Ventricular Premature Complexes | 1 | 2024 | 7 | 0.250 |
Why?
|
Fatty Acids | 2 | 2016 | 130 | 0.240 |
Why?
|
Influenza, Human | 2 | 2017 | 329 | 0.240 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2024 | 30 | 0.240 |
Why?
|
Renal Dialysis | 2 | 2024 | 355 | 0.240 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2024 | 54 | 0.240 |
Why?
|
Cognition | 2 | 2020 | 570 | 0.240 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2024 | 97 | 0.230 |
Why?
|
Myocarditis | 1 | 2024 | 50 | 0.230 |
Why?
|
Arterial Switch Operation | 1 | 2023 | 5 | 0.230 |
Why?
|
Echocardiography | 4 | 2023 | 911 | 0.230 |
Why?
|
Pancreatitis | 1 | 2023 | 87 | 0.230 |
Why?
|
Transposition of Great Vessels | 1 | 2023 | 23 | 0.230 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2013 | 35 | 0.230 |
Why?
|
Incidence | 5 | 2021 | 1577 | 0.220 |
Why?
|
Multiple Organ Failure | 1 | 2023 | 53 | 0.220 |
Why?
|
Fusobacterium nucleatum | 1 | 2022 | 4 | 0.220 |
Why?
|
Patient Compliance | 2 | 2017 | 227 | 0.220 |
Why?
|
Longitudinal Studies | 4 | 2021 | 1019 | 0.220 |
Why?
|
Infant, Newborn, Diseases | 1 | 2023 | 111 | 0.220 |
Why?
|
Ohio | 5 | 2021 | 37 | 0.220 |
Why?
|
Cohort Effect | 1 | 2021 | 6 | 0.210 |
Why?
|
Biliary Atresia | 1 | 2022 | 22 | 0.210 |
Why?
|
Linear Models | 2 | 2014 | 421 | 0.210 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 45 | 0.210 |
Why?
|
Adult Children | 1 | 2021 | 12 | 0.210 |
Why?
|
Poverty | 2 | 2021 | 173 | 0.210 |
Why?
|
Metagenomics | 1 | 2022 | 83 | 0.210 |
Why?
|
Streptococcal Infections | 1 | 2022 | 57 | 0.210 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2021 | 27 | 0.210 |
Why?
|
Cholestasis | 1 | 2022 | 47 | 0.200 |
Why?
|
Bacterial Load | 1 | 2021 | 16 | 0.200 |
Why?
|
Logistic Models | 4 | 2013 | 1186 | 0.200 |
Why?
|
Survivors | 2 | 2015 | 226 | 0.200 |
Why?
|
Aortic Valve Insufficiency | 1 | 2023 | 130 | 0.200 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 134 | 0.200 |
Why?
|
Internship and Residency | 5 | 2023 | 1004 | 0.200 |
Why?
|
Syncope | 1 | 2021 | 34 | 0.200 |
Why?
|
Predictive Value of Tests | 6 | 2023 | 1673 | 0.200 |
Why?
|
Mental Recall | 2 | 2015 | 159 | 0.200 |
Why?
|
Respiratory Tract Diseases | 1 | 2021 | 45 | 0.200 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2023 | 139 | 0.200 |
Why?
|
Tissue Donors | 2 | 2022 | 463 | 0.200 |
Why?
|
Analysis of Variance | 2 | 2014 | 912 | 0.200 |
Why?
|
Mycobiome | 1 | 2020 | 1 | 0.200 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2020 | 14 | 0.190 |
Why?
|
Pediatric Obesity | 1 | 2021 | 22 | 0.190 |
Why?
|
Tetralogy of Fallot | 1 | 2021 | 44 | 0.190 |
Why?
|
Erythropoiesis | 1 | 2021 | 52 | 0.190 |
Why?
|
Mitral Valve Insufficiency | 1 | 2023 | 187 | 0.190 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 806 | 0.190 |
Why?
|
Atrial Function, Left | 1 | 2021 | 46 | 0.190 |
Why?
|
Thrombophilia | 1 | 2020 | 22 | 0.190 |
Why?
|
Electric Countershock | 1 | 2021 | 47 | 0.190 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 45 | 0.190 |
Why?
|
Decision Making | 2 | 2020 | 642 | 0.190 |
Why?
|
Atrial Function | 1 | 2020 | 17 | 0.190 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2021 | 51 | 0.190 |
Why?
|
Risk Adjustment | 1 | 2020 | 39 | 0.190 |
Why?
|
Carcinogenesis | 1 | 2022 | 195 | 0.190 |
Why?
|
Hypertriglyceridemia | 1 | 2021 | 67 | 0.190 |
Why?
|
Electrodes, Implanted | 1 | 2021 | 171 | 0.190 |
Why?
|
Electrocardiography | 2 | 2020 | 478 | 0.190 |
Why?
|
Blood Gas Analysis | 1 | 2020 | 37 | 0.190 |
Why?
|
Bacteria | 2 | 2021 | 447 | 0.190 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2020 | 87 | 0.190 |
Why?
|
Life Style | 2 | 2011 | 189 | 0.190 |
Why?
|
Environmental Monitoring | 1 | 2020 | 71 | 0.190 |
Why?
|
Cardiology | 1 | 2021 | 123 | 0.190 |
Why?
|
Air Pollution | 1 | 2021 | 68 | 0.190 |
Why?
|
Secondary Prevention | 1 | 2021 | 162 | 0.180 |
Why?
|
Delirium | 1 | 2021 | 66 | 0.180 |
Why?
|
Primary Prevention | 1 | 2021 | 85 | 0.180 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2020 | 104 | 0.180 |
Why?
|
Arrhythmias, Cardiac | 1 | 2021 | 187 | 0.180 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2020 | 52 | 0.180 |
Why?
|
Tachycardia, Ventricular | 1 | 2021 | 115 | 0.180 |
Why?
|
Asymptomatic Diseases | 1 | 2020 | 41 | 0.180 |
Why?
|
Age Factors | 4 | 2021 | 1851 | 0.180 |
Why?
|
Air Pollution, Indoor | 1 | 2020 | 63 | 0.180 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2019 | 19 | 0.180 |
Why?
|
Transplant Recipients | 1 | 2020 | 122 | 0.180 |
Why?
|
Patient Simulation | 1 | 2019 | 42 | 0.170 |
Why?
|
Carbon Dioxide | 1 | 2020 | 188 | 0.170 |
Why?
|
Hypertension, Pulmonary | 1 | 2023 | 346 | 0.170 |
Why?
|
Wound Healing | 1 | 2021 | 344 | 0.170 |
Why?
|
Norwood Procedures | 1 | 2019 | 35 | 0.170 |
Why?
|
Influenza Vaccines | 2 | 2017 | 142 | 0.170 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 129 | 0.170 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 159 | 0.170 |
Why?
|
Colectomy | 1 | 2020 | 167 | 0.170 |
Why?
|
Motor Activity | 2 | 2012 | 327 | 0.170 |
Why?
|
Environmental Exposure | 1 | 2021 | 296 | 0.170 |
Why?
|
Aged, 80 and over | 7 | 2019 | 6509 | 0.170 |
Why?
|
Sleep Apnea Syndromes | 1 | 2020 | 103 | 0.170 |
Why?
|
Self Report | 2 | 2017 | 288 | 0.170 |
Why?
|
Hemorrhage | 1 | 2020 | 268 | 0.170 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 202 | 0.170 |
Why?
|
Formative Feedback | 1 | 2018 | 13 | 0.160 |
Why?
|
Parents | 2 | 2018 | 272 | 0.160 |
Why?
|
Family | 1 | 2020 | 311 | 0.160 |
Why?
|
Professional-Family Relations | 1 | 2018 | 48 | 0.160 |
Why?
|
Treatment Outcome | 8 | 2023 | 7993 | 0.160 |
Why?
|
Professional Competence | 1 | 2018 | 68 | 0.160 |
Why?
|
Aorta | 1 | 2019 | 280 | 0.160 |
Why?
|
Coronary Vessels | 1 | 2019 | 177 | 0.160 |
Why?
|
Vaccination Coverage | 1 | 2017 | 5 | 0.160 |
Why?
|
Calcinosis | 1 | 2019 | 224 | 0.160 |
Why?
|
Thrombosis | 1 | 2020 | 296 | 0.160 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 567 | 0.160 |
Why?
|
Extracellular Matrix | 1 | 2019 | 232 | 0.160 |
Why?
|
Aortic Valve Stenosis | 1 | 2019 | 131 | 0.150 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2021 | 212 | 0.150 |
Why?
|
Quality Improvement | 2 | 2021 | 428 | 0.150 |
Why?
|
Books | 1 | 2017 | 4 | 0.150 |
Why?
|
Aortic Valve | 1 | 2019 | 222 | 0.150 |
Why?
|
Pamphlets | 1 | 2017 | 14 | 0.150 |
Why?
|
Heart Rate | 1 | 2020 | 492 | 0.150 |
Why?
|
Gene Expression | 1 | 2021 | 1284 | 0.150 |
Why?
|
Learning | 2 | 2019 | 280 | 0.150 |
Why?
|
Sudden Infant Death | 1 | 2017 | 25 | 0.150 |
Why?
|
Office Visits | 1 | 2017 | 44 | 0.150 |
Why?
|
Preventive Health Services | 1 | 2017 | 37 | 0.150 |
Why?
|
Hemodynamics | 1 | 2020 | 710 | 0.150 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 262 | 0.150 |
Why?
|
Meat | 2 | 2016 | 26 | 0.150 |
Why?
|
Vulnerable Populations | 1 | 2017 | 76 | 0.150 |
Why?
|
Child Health Services | 1 | 2017 | 49 | 0.150 |
Why?
|
Lactation | 1 | 2016 | 53 | 0.140 |
Why?
|
Diet, Mediterranean | 1 | 2016 | 6 | 0.140 |
Why?
|
Patient Discharge | 1 | 2019 | 300 | 0.140 |
Why?
|
Risk | 3 | 2017 | 674 | 0.140 |
Why?
|
Feces | 3 | 2023 | 319 | 0.140 |
Why?
|
Dietary Fats | 3 | 2013 | 135 | 0.140 |
Why?
|
Interviews as Topic | 1 | 2017 | 319 | 0.140 |
Why?
|
Trisaccharides | 1 | 2015 | 12 | 0.140 |
Why?
|
Stroke Volume | 3 | 2024 | 456 | 0.140 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2016 | 27 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2016 | 65 | 0.140 |
Why?
|
Short Bowel Syndrome | 1 | 2015 | 37 | 0.130 |
Why?
|
Health Promotion | 1 | 2017 | 160 | 0.130 |
Why?
|
Shellfish | 1 | 2015 | 5 | 0.130 |
Why?
|
Neoplasms | 1 | 2011 | 2898 | 0.130 |
Why?
|
Seafood | 1 | 2015 | 10 | 0.130 |
Why?
|
Physicians | 1 | 2023 | 673 | 0.130 |
Why?
|
Mortality | 1 | 2016 | 149 | 0.130 |
Why?
|
Internet | 1 | 2017 | 312 | 0.130 |
Why?
|
Severity of Illness Index | 4 | 2022 | 1801 | 0.130 |
Why?
|
SEER Program | 2 | 2013 | 190 | 0.130 |
Why?
|
Overweight | 1 | 2015 | 118 | 0.120 |
Why?
|
Dietary Fiber | 2 | 2013 | 43 | 0.120 |
Why?
|
Adipokines | 1 | 2014 | 19 | 0.120 |
Why?
|
Tocopherols | 1 | 2013 | 6 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 3362 | 0.120 |
Why?
|
Pilot Projects | 3 | 2022 | 839 | 0.120 |
Why?
|
Bone Density | 1 | 2015 | 209 | 0.120 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 78 | 0.120 |
Why?
|
Diet Surveys | 1 | 2013 | 20 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 2601 | 0.110 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 306 | 0.110 |
Why?
|
Asthma | 1 | 2021 | 955 | 0.110 |
Why?
|
Lymphoma, Follicular | 1 | 2013 | 70 | 0.110 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 275 | 0.110 |
Why?
|
Factor Analysis, Statistical | 1 | 2013 | 111 | 0.110 |
Why?
|
Survival Analysis | 2 | 2014 | 1538 | 0.110 |
Why?
|
Nebraska | 1 | 2012 | 14 | 0.110 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 28 | 0.110 |
Why?
|
Vitamin B 6 | 1 | 2012 | 3 | 0.110 |
Why?
|
Erythrocyte Membrane | 1 | 2012 | 60 | 0.110 |
Why?
|
Intestines | 1 | 2015 | 411 | 0.110 |
Why?
|
Environment Design | 1 | 2012 | 9 | 0.110 |
Why?
|
Exercise | 4 | 2021 | 315 | 0.110 |
Why?
|
Primary Health Care | 3 | 2021 | 339 | 0.110 |
Why?
|
Cause of Death | 1 | 2013 | 277 | 0.110 |
Why?
|
Genistein | 1 | 2011 | 16 | 0.110 |
Why?
|
Lipoproteins, HDL | 2 | 2023 | 96 | 0.100 |
Why?
|
Abdominal Pain | 2 | 2023 | 137 | 0.100 |
Why?
|
Nipple Aspirate Fluid | 1 | 2011 | 1 | 0.100 |
Why?
|
Soybean Proteins | 1 | 2011 | 5 | 0.100 |
Why?
|
Estrone | 1 | 2011 | 10 | 0.100 |
Why?
|
Geography | 1 | 2012 | 223 | 0.100 |
Why?
|
Gestational Age | 2 | 2023 | 311 | 0.100 |
Why?
|
Cataract | 1 | 2011 | 86 | 0.100 |
Why?
|
Prognosis | 2 | 2021 | 3679 | 0.100 |
Why?
|
Dietary Sucrose | 1 | 2010 | 13 | 0.100 |
Why?
|
Organ Size | 2 | 2022 | 364 | 0.100 |
Why?
|
Estradiol | 1 | 2011 | 252 | 0.090 |
Why?
|
Hypertension | 1 | 2019 | 1141 | 0.090 |
Why?
|
Inflammation | 3 | 2023 | 920 | 0.090 |
Why?
|
Saliva | 2 | 2021 | 122 | 0.090 |
Why?
|
Databases, Factual | 1 | 2013 | 814 | 0.090 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 592 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 383 | 0.090 |
Why?
|
Attitude to Health | 1 | 2010 | 220 | 0.080 |
Why?
|
Los Angeles | 3 | 2013 | 28 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2022 | 860 | 0.080 |
Why?
|
Time Factors | 3 | 2023 | 5210 | 0.080 |
Why?
|
Vaccination | 2 | 2022 | 254 | 0.080 |
Why?
|
Neoplasm Staging | 1 | 2013 | 1939 | 0.080 |
Why?
|
Kidney | 2 | 2024 | 1241 | 0.080 |
Why?
|
Mass Screening | 2 | 2023 | 618 | 0.080 |
Why?
|
Residence Characteristics | 2 | 2019 | 197 | 0.070 |
Why?
|
Triglycerides | 2 | 2021 | 232 | 0.070 |
Why?
|
Biomarkers | 3 | 2023 | 1718 | 0.070 |
Why?
|
Cholesterol, HDL | 2 | 2021 | 165 | 0.070 |
Why?
|
Survival Rate | 2 | 2021 | 1863 | 0.070 |
Why?
|
Cholesterol | 2 | 2021 | 356 | 0.070 |
Why?
|
Genetic Variation | 1 | 2012 | 1351 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 744 | 0.060 |
Why?
|
Animals | 4 | 2023 | 26582 | 0.060 |
Why?
|
Biomarkers, Tumor | 1 | 2013 | 1464 | 0.060 |
Why?
|
Guanylate Cyclase | 1 | 2023 | 18 | 0.060 |
Why?
|
Case Management | 1 | 2023 | 24 | 0.060 |
Why?
|
Renal Replacement Therapy | 1 | 2024 | 30 | 0.060 |
Why?
|
Cross-Over Studies | 2 | 2017 | 399 | 0.060 |
Why?
|
Butyrates | 1 | 2023 | 42 | 0.060 |
Why?
|
Politics | 1 | 2023 | 50 | 0.060 |
Why?
|
Catastrophization | 1 | 2023 | 7 | 0.060 |
Why?
|
Infant Mortality | 1 | 2023 | 59 | 0.060 |
Why?
|
Carbohydrates | 1 | 2023 | 47 | 0.060 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2023 | 39 | 0.060 |
Why?
|
Dilatation | 1 | 2023 | 48 | 0.060 |
Why?
|
Dysbiosis | 1 | 2023 | 70 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 2271 | 0.060 |
Why?
|
Mice | 3 | 2023 | 11352 | 0.050 |
Why?
|
Triage | 1 | 2023 | 108 | 0.050 |
Why?
|
Diet, High-Fat | 1 | 2023 | 114 | 0.050 |
Why?
|
Shock, Septic | 1 | 2023 | 102 | 0.050 |
Why?
|
Ventricular Function, Right | 1 | 2023 | 142 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 2360 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 318 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2023 | 196 | 0.050 |
Why?
|
Bile Ducts | 1 | 2022 | 59 | 0.050 |
Why?
|
Aorta, Thoracic | 1 | 2023 | 165 | 0.050 |
Why?
|
Patient Reported Outcome Measures | 1 | 2023 | 166 | 0.050 |
Why?
|
Vehicle Emissions | 1 | 2021 | 3 | 0.050 |
Why?
|
Pregnancy in Diabetics | 1 | 2021 | 37 | 0.050 |
Why?
|
Acute Disease | 1 | 2023 | 826 | 0.050 |
Why?
|
Anthropometry | 1 | 2021 | 74 | 0.050 |
Why?
|
Sputum | 1 | 2021 | 34 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 1373 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2024 | 334 | 0.050 |
Why?
|
Morbidity | 1 | 2021 | 148 | 0.050 |
Why?
|
Prescriptions | 1 | 2021 | 21 | 0.050 |
Why?
|
Travel | 1 | 2021 | 68 | 0.050 |
Why?
|
Air Microbiology | 1 | 2020 | 5 | 0.050 |
Why?
|
Heart Block | 1 | 2020 | 32 | 0.050 |
Why?
|
Social Class | 1 | 2021 | 128 | 0.050 |
Why?
|
Gastrointestinal Agents | 1 | 2022 | 161 | 0.050 |
Why?
|
Knowledge | 1 | 2020 | 29 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2021 | 213 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2023 | 319 | 0.050 |
Why?
|
Fetal Growth Retardation | 1 | 2021 | 66 | 0.050 |
Why?
|
DNA, Fungal | 1 | 2020 | 57 | 0.050 |
Why?
|
Ventricular Pressure | 1 | 2020 | 34 | 0.050 |
Why?
|
Dust | 1 | 2020 | 26 | 0.050 |
Why?
|
Housing | 1 | 2020 | 42 | 0.050 |
Why?
|
North America | 1 | 2021 | 180 | 0.050 |
Why?
|
Hospitals | 1 | 2023 | 294 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2022 | 510 | 0.050 |
Why?
|
Chemoprevention | 1 | 2020 | 91 | 0.050 |
Why?
|
Exercise Tolerance | 1 | 2020 | 48 | 0.050 |
Why?
|
International Cooperation | 1 | 2020 | 127 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2021 | 232 | 0.050 |
Why?
|
Methionine | 1 | 2020 | 66 | 0.050 |
Why?
|
Fungi | 1 | 2020 | 65 | 0.050 |
Why?
|
Exercise Test | 1 | 2021 | 164 | 0.050 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 267 | 0.050 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2021 | 99 | 0.050 |
Why?
|
Artificial Intelligence | 1 | 2023 | 298 | 0.050 |
Why?
|
Drug Monitoring | 1 | 2020 | 118 | 0.050 |
Why?
|
Critical Care | 1 | 2023 | 370 | 0.050 |
Why?
|
Respiratory System | 1 | 2020 | 116 | 0.050 |
Why?
|
DNA, Bacterial | 1 | 2020 | 236 | 0.040 |
Why?
|
Meglumine | 1 | 2019 | 39 | 0.040 |
Why?
|
Elastic Tissue | 1 | 2019 | 18 | 0.040 |
Why?
|
Palliative Care | 1 | 2021 | 257 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2022 | 1047 | 0.040 |
Why?
|
Depression | 1 | 2023 | 473 | 0.040 |
Why?
|
Polysomnography | 1 | 2020 | 151 | 0.040 |
Why?
|
Placenta | 1 | 2021 | 175 | 0.040 |
Why?
|
Heart Atria | 1 | 2021 | 250 | 0.040 |
Why?
|
Autopsy | 1 | 2019 | 116 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2020 | 239 | 0.040 |
Why?
|
Recovery of Function | 1 | 2020 | 272 | 0.040 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2019 | 47 | 0.040 |
Why?
|
Organometallic Compounds | 1 | 2019 | 132 | 0.040 |
Why?
|
ROC Curve | 1 | 2020 | 752 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 746 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2020 | 751 | 0.040 |
Why?
|
Informed Consent | 1 | 2020 | 266 | 0.040 |
Why?
|
Computers, Handheld | 1 | 2018 | 32 | 0.040 |
Why?
|
Poverty Areas | 1 | 2018 | 37 | 0.040 |
Why?
|
Cell Phone | 1 | 2018 | 37 | 0.040 |
Why?
|
Registries | 1 | 2021 | 702 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2022 | 669 | 0.040 |
Why?
|
Artifacts | 1 | 2019 | 244 | 0.040 |
Why?
|
Patient Selection | 1 | 2021 | 685 | 0.040 |
Why?
|
Social Work | 1 | 2017 | 19 | 0.040 |
Why?
|
Clinical Competence | 1 | 2023 | 751 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2022 | 426 | 0.040 |
Why?
|
Dairy Products | 1 | 2016 | 11 | 0.040 |
Why?
|
Video Recording | 1 | 2018 | 190 | 0.040 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2022 | 930 | 0.040 |
Why?
|
Mexico | 1 | 2016 | 67 | 0.040 |
Why?
|
Prevalence | 1 | 2021 | 1239 | 0.040 |
Why?
|
Attitude | 1 | 2017 | 127 | 0.040 |
Why?
|
Liver | 1 | 2022 | 1230 | 0.040 |
Why?
|
Patient Preference | 1 | 2017 | 105 | 0.040 |
Why?
|
Deoxyguanosine | 1 | 2016 | 28 | 0.030 |
Why?
|
China | 1 | 2016 | 228 | 0.030 |
Why?
|
Teaching | 1 | 2017 | 147 | 0.030 |
Why?
|
Program Evaluation | 1 | 2017 | 297 | 0.030 |
Why?
|
Cecum | 1 | 2015 | 68 | 0.030 |
Why?
|
Urban Population | 1 | 2017 | 213 | 0.030 |
Why?
|
Croatia | 1 | 2015 | 1 | 0.030 |
Why?
|
Biopsy | 1 | 2019 | 1163 | 0.030 |
Why?
|
Quality of Life | 1 | 2023 | 1585 | 0.030 |
Why?
|
Ileum | 1 | 2015 | 159 | 0.030 |
Why?
|
Weight Gain | 1 | 2015 | 123 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2022 | 2232 | 0.030 |
Why?
|
Disease Progression | 1 | 2019 | 1531 | 0.030 |
Why?
|
Neoplasm Grading | 1 | 2016 | 357 | 0.030 |
Why?
|
Digestive System Surgical Procedures | 1 | 2015 | 120 | 0.030 |
Why?
|
Contrast Media | 1 | 2019 | 1078 | 0.030 |
Why?
|
Body Fat Distribution | 1 | 2014 | 13 | 0.030 |
Why?
|
Regression Analysis | 1 | 2015 | 596 | 0.030 |
Why?
|
Sex Factors | 1 | 2017 | 1054 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2015 | 271 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 927 | 0.030 |
Why?
|
Xanthophylls | 1 | 2013 | 2 | 0.030 |
Why?
|
Cryptoxanthins | 1 | 2013 | 2 | 0.030 |
Why?
|
beta Carotene | 1 | 2013 | 4 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2017 | 319 | 0.030 |
Why?
|
Dietary Proteins | 1 | 2013 | 30 | 0.030 |
Why?
|
Dietary Carbohydrates | 1 | 2013 | 38 | 0.030 |
Why?
|
Micronutrients | 1 | 2013 | 17 | 0.030 |
Why?
|
Vitamin E | 1 | 2013 | 35 | 0.030 |
Why?
|
Maintenance Chemotherapy | 1 | 2013 | 76 | 0.030 |
Why?
|
Australia | 1 | 2013 | 99 | 0.030 |
Why?
|
Rituximab | 1 | 2013 | 116 | 0.030 |
Why?
|
Folic Acid | 1 | 2013 | 60 | 0.030 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2012 | 11 | 0.030 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2012 | 10 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2012 | 17 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2016 | 447 | 0.030 |
Why?
|
Sleep | 1 | 2017 | 444 | 0.030 |
Why?
|
Oleic Acid | 1 | 2012 | 14 | 0.030 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2012 | 11 | 0.030 |
Why?
|
Mutagens | 1 | 2012 | 31 | 0.030 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2012 | 44 | 0.030 |
Why?
|
Phenotype | 1 | 2019 | 2378 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2014 | 256 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 315 | 0.030 |
Why?
|
Quinoxalines | 1 | 2012 | 50 | 0.030 |
Why?
|
Physical Exertion | 1 | 2012 | 39 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2012 | 229 | 0.030 |
Why?
|
Antioxidants | 1 | 2013 | 223 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 916 | 0.030 |
Why?
|
Isoenzymes | 1 | 2012 | 271 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 2011 | 155 | 0.030 |
Why?
|
Premenopause | 1 | 2011 | 54 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 1204 | 0.020 |
Why?
|
Lipids | 1 | 2012 | 269 | 0.020 |
Why?
|
Sex Distribution | 1 | 2011 | 173 | 0.020 |
Why?
|
Japan | 1 | 2011 | 307 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 552 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2011 | 193 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 683 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2012 | 999 | 0.020 |
Why?
|
Vitamin D | 1 | 2011 | 261 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 3092 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 865 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 1169 | 0.020 |
Why?
|